This was a highly-educational scientific event, organised by the Institute of Applied Biosciences/The Centre for Research and Technology, Hellas (INAB/CERTH) at Thessaloniki, Greece. The venue was INAB and the event took place on June 4, 2016.
The scientific program was built around the integration of biomarkers when managing patients with chronic lymphocytic leukemia (CLL). In particular the focus was on gene TP53. The coordination of the event was towards not solely the direction of presenting results, but sharing knowledge in an interactive fashion as well. More specifically, the event included two interactive sessions where the audience had the opportunity to actively participate in the discussion. Even more, interaction among the participants was successfully encouraged throughout the event leading to a fruitful, educational and training experience.